Martin Bak

4.3k total citations
91 papers, 3.3k citations indexed

About

Martin Bak is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Martin Bak has authored 91 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 27 papers in Molecular Biology and 25 papers in Cancer Research. Recurrent topics in Martin Bak's work include Neuroscience and Neural Engineering (17 papers), Breast Cancer Treatment Studies (12 papers) and EEG and Brain-Computer Interfaces (11 papers). Martin Bak is often cited by papers focused on Neuroscience and Neural Engineering (17 papers), Breast Cancer Treatment Studies (12 papers) and EEG and Brain-Computer Interfaces (11 papers). Martin Bak collaborates with scholars based in Denmark, United States and Sweden. Martin Bak's co-authors include E. M. Schmidt, J.S. McIntosh, Conrad Kufta, F. Terry Hambrecht, Torben A. Kruse, Mads Thomassen, Flemming Brandt Sørensen, Steinbjørn Hansen, D. Grabau and Martin J. Larsen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Martin Bak

89 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Bak Denmark 32 1.2k 982 871 733 639 91 3.3k
Peter C. Warnke United States 35 605 0.5× 837 0.9× 262 0.3× 414 0.6× 498 0.8× 129 4.7k
Michael Schirner Germany 35 171 0.1× 1.6k 1.7× 729 0.8× 454 0.6× 1.0k 1.6× 101 4.2k
Yirui Sun China 21 746 0.6× 1.2k 1.2× 202 0.2× 218 0.3× 187 0.3× 54 3.0k
Arvind Ahuja India 25 570 0.5× 232 0.2× 283 0.3× 87 0.1× 218 0.3× 168 2.1k
Niklas Thon Germany 32 610 0.5× 1.0k 1.0× 171 0.2× 656 0.9× 342 0.5× 129 3.8k
Atsushi Natsume Japan 42 306 0.3× 2.4k 2.5× 111 0.1× 1.1k 1.6× 1.3k 2.1× 189 5.2k
Sieger Leenstra Netherlands 37 565 0.5× 1.9k 2.0× 118 0.1× 902 1.2× 1.1k 1.7× 112 5.1k
Jun Maeda Japan 29 220 0.2× 1.1k 1.1× 165 0.2× 122 0.2× 294 0.5× 111 2.7k
Haodi Wu United States 31 703 0.6× 2.3k 2.3× 61 0.1× 210 0.3× 281 0.4× 56 3.6k
Hirokazu Sakaguchi Japan 34 745 0.6× 1.2k 1.3× 221 0.3× 52 0.1× 76 0.1× 158 5.3k

Countries citing papers authored by Martin Bak

Since Specialization
Citations

This map shows the geographic impact of Martin Bak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Bak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Bak more than expected).

Fields of papers citing papers by Martin Bak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Bak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Bak. The network helps show where Martin Bak may publish in the future.

Co-authorship network of co-authors of Martin Bak

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Bak. A scholar is included among the top collaborators of Martin Bak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Bak. Martin Bak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ehmsen, Sidse, Sofie Traynor, N I Nissen, et al.. (2025). RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer. Frontiers in Oncology. 14. 1497093–1497093. 1 indexed citations
2.
Eliáš, Daniel, Carla L. Alves, Martin V. Bennetzen, et al.. (2021). MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. npj Breast Cancer. 7(1). 2–2. 11 indexed citations
3.
Pedersen, Martin H., Brian L. Hood, Sidse Ehmsen, et al.. (2018). CYPOR is a novel and independent prognostic biomarker of recurrence‐free survival in triple‐negative breast cancer patients. International Journal of Cancer. 144(3). 631–640. 20 indexed citations
4.
Alves, Carla L., Daniel Eliáš, Maria Lyng, et al.. (2016). High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research. 22(22). 5514–5526. 53 indexed citations
5.
Troyk, Philip R., Stuart F. Cogan, Mario I. Romero‐Ortega, et al.. (2015). In-vivo tests of a 16-channel implantable wireless neural stimulator. 474–477. 18 indexed citations
6.
Yde, Christina W., Anne‐Vibeke Lænkholm, Birgitte Rasmussen, et al.. (2015). Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer. BMC Cancer. 15(1). 239–239. 21 indexed citations
7.
Sørensen, Kristina P., Mads Thomassen, Qihua Tan, et al.. (2015). Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers. Breast Cancer Research. 17(1). 55–55. 50 indexed citations
8.
Sørensen, Kristina P., Mads Thomassen, Qihua Tan, et al.. (2013). Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Research and Treatment. 142(3). 529–536. 226 indexed citations
9.
Tang, Mariann, Martin Bak, Karsten Hindsholm, et al.. (2013). Antiplatelet therapy at the time of coronary artery bypass grafting: a multicentre cohort study. European Journal of Cardio-Thoracic Surgery. 44(2). e133–e140. 32 indexed citations
10.
Vejborg, Ilse, Ellen M. Mikkelsen, Jens Peter Garne, et al.. (2011). Mammography screening in Denmark.. PubMed. 58(6). C4287–C4287. 26 indexed citations
11.
Kim, Tae Soo, Philip R. Troyk, & Martin Bak. (2006). Active Floating Micro Electrode Arrays (AFMA). PubMed. 2006. 2807–2810. 9 indexed citations
12.
Vyberg, Mogens, et al.. (2005). Patologidatabanken. Dansk Selskab for Patologisk Anatomi og Cytologi. Ugeskrift for Læger. 167.
13.
Hildebrandt, Malene Grubbe, Peter Bartram, Martin Bak, et al.. (2005). Low risk of recurrence in breast cancer with negative sentinel node.. University of Southern Denmark Research Portal (University of Southern Denmark). 58(31). 120–127. 4 indexed citations
14.
Njor, Sisse Helle, Anne Helene Olsen, U Dyreborg, et al.. (2003). Mammography screening in the county of Fyn. November 1993-December 1999.. PubMed. 1–33. 37 indexed citations
15.
Flyvbjerg, Allan, et al.. (2001). Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. Journal of Endocrinology. 170(3). 647–651. 78 indexed citations
16.
Bak, Martin, et al.. (2000). Renal Enlargement Precedes Renal Hyperfiltration in Early Experimental Diabetes in Rats. Journal of the American Society of Nephrology. 11(7). 1287–1292. 69 indexed citations
17.
Hansen, Steinbjørn, D. Grabau, Flemming Brandt Sørensen, et al.. (2000). Vascular grading of angiogenesis: prognostic significance in breast cancer. British Journal of Cancer. 82(2). 339–347. 69 indexed citations
18.
Bak, Martin, et al.. (1994). Renal Adaptations to Continuous Administration of Furosemide and Bendroflumethiazide in Rats. Pharmacology & Toxicology. 74(6). 216–222. 10 indexed citations
19.
Petersen, Steffen E., et al.. (1991). Chromosome number distribution and cellular DNA content in colorectal adenomas from polyposis and nonpolyposis patients. Cancer Genetics and Cytogenetics. 53(2). 219–228. 2 indexed citations
20.
Bak, Martin & P. Stubbe Teglbjærg. (1989). Pleomorphic (giant cell) carcinoma of the intestine. An immunohistochemical and electron microscopic study. Cancer. 64(12). 2557–2564. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter C. Warnke Breakdown of academic impact, for papers by Michael Schirner Breakdown of academic impact, for papers by Yirui Sun Breakdown of academic impact, for papers by Arvind Ahuja Breakdown of academic impact, for papers by Niklas Thon Breakdown of academic impact, for papers by Atsushi Natsume Breakdown of academic impact, for papers by Sieger Leenstra Breakdown of academic impact, for papers by Jun Maeda Breakdown of academic impact, for papers by Haodi Wu Breakdown of academic impact, for papers by Hirokazu Sakaguchi
Rankless by CCL
2026